Cyclohexanone → 6-chloro-N-(4-{[4-(cyclohexylamino)cyclohexyl]methyl}cyclohexyl)-4-(5-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyridin-2-amine

HRID 2089044

반응식

HRID 2089044 반응식
[NH2:1][CH:2]1[CH2:7][CH2:6][CH:5]([CH2:8][CH:9]2[CH2:14][CH2:13][CH:12]([NH:15][C:16]3[CH:21]=[C:20]([C:22]4[C:30]5[C:25](=[N:26][CH:27]=[C:28]([O:31][CH3:32])[CH:29]=5)[NH:24][CH:23]=4)[CH:19]=[C:18]([Cl:33])[N:17]=3)[CH2:11][CH2:10]2)[CH2:4][CH2:3]1.[C:34]1(=O)[CH2:39][CH2:38][CH2:37][CH2:36][CH2:35]1.C([BH3-])#N.[Na+]>CO.[Cl-].[Zn+2].[Cl-]>[Cl:33][C:18]1[N:17]=[C:16]([NH:15][CH:12]2[CH2:11][CH2:10][CH:9]([CH2:8][CH:5]3[CH2:6][CH2:7][CH:2]([NH:1][CH:34]4[CH2:39][CH2:38][CH2:37][CH2:36][CH2:35]4)[CH2:3][CH2:4]3)[CH2:14][CH2:13]2)[CH:21]=[C:20]([C:22]2[C:30]3[C:25](=[N:26][CH:27]=[C:28]([O:31][CH3:32])[CH:29]=3)[NH:24][CH:23]=2)[CH:19]=1

참가 물질

6

실험 절차

A suspension of Example 237 (80.0 mg, 0.171 mmol) in MeOH (3 mL) was treated with cyclohexanone (0.035 mL, 0.342 mmol). After 30 minutes, sodium cyanoborohydride (21.5 mg, 0.342 mmol) and zinc chloride (0.699 mg, 5.13 μmol) were added. The reaction was stirred at room temperature overnight. The mixture was concentrated. The residue was treated with sat. NaHCO3 and extracted with EtOAc (2×). The combined organic layers were dried and purified by reverse-phase HPLC as described in Example 56 to give the title compound (32.4 mg) as trifluoroacetic acid salts. 1H NMR (400 MHz, CD3OD) ppm 0.96-1.48 (m, 15H), 1.59-1.96 (m, 10H), 2.01-2.17 (m, 5H), 3.12-3.23 (m, 2H), 3.70 (m, 1H), 3.96 (s, 3H), 6.84-7.01 (m, 2H), 7.93 (m, 1H), 7.99 (s, 1H), 8.10 (s, 1H). MS (DCI+) m/z 550.4 (M+H)+.

후처리

  1. concentrationThe mixture was concentrated
  2. additionThe residue was treated with sat. NaHCO3
  3. extractionextracted with EtOAc (2×)
  4. customThe combined organic layers were dried
  5. custompurified by reverse-phase HPLC

출처 및 근거

ORD 기록
ord-d3fd9965c7a1477885fa3ac2000d29f9
출처 데이터셋
uspto-grants-2013_05
특허 번호
US08435980B2

연결된 노트

불러오는 중…